Cargando…
No Added Value of Novel Biomarkers in the Diagnostic Assessment of Patients Suspected of Acute Coronary Syndrome
BACKGROUND: Despite the availability of high-sensitive troponin (hs-cTnT), there is still room for improvement in the diagnostic assessment of patients suspected of acute coronary syndrome (ACS). Apart from serial biomarker testing, which is time-consuming, novel biomarkers like copeptin have been p...
Autores principales: | Poldervaart, Judith M., Röttger, Emma, Dekker, Marieke S., Zuithoff, Nicolaas P. A., Verheggen, Peter W. H. M., de Vrey, Evelyn A., Wildbergh, Thierry X., van ‘t Hof, Arnoud W. J., Mosterd, Arend, Hoes, Arno W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503345/ https://www.ncbi.nlm.nih.gov/pubmed/26177390 http://dx.doi.org/10.1371/journal.pone.0132000 |
Ejemplares similares
-
Time trends in the use and appropriateness of natriuretic peptide testing in primary care: an observational study
por: Valk, Mark, et al.
Publicado: (2020) -
COPD in patients with stable heart failure in the primary care setting
por: Valk, Mark J, et al.
Publicado: (2015) -
Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAs
por: Oerlemans, Martinus I F J, et al.
Publicado: (2012) -
Epidemiology of heart failure
por: Groenewegen, Amy, et al.
Publicado: (2020) -
Secondary analysis of frequency, circumstances and consequences of calculation errors of the HEART (history, ECG, age, risk factors and troponin) score at the emergency departments of nine hospitals in the Netherlands
por: Ras, Marten, et al.
Publicado: (2017)